Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Photosensitivity reaction
ADR ID BADD_A03419
ADR Hierarchy
23      Skin and subcutaneous tissue disorders
23.03      Epidermal and dermal conditions
23.03.09      Photosensitivity and photodermatosis conditions
23.03.09.003      Photosensitivity reaction
Description A nonimmunologic, chemically induced type of photosensitivity producing a sometimes vesiculating dermatitis. It results in hyperpigmentation and desquamation of the light-exposed areas of the skin. [MeSH]
MedDRA Code 10034972
MeSH ID D017484; D017454
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Contact dermatitis and other eczema due to solar radiation | Dermatitis of exposed site | Dermatitis photosensitive | Eruption of exposed site | Exogenous photosensitive eruption | Photosensitive dermatitis | Photosensitive rash | Photosensitive reaction | Photosensitivity | Photosensitivity (NOS) | Photosensitivity allergic reac | Photosensitivity allergic react | Photosensitivity allergic reaction | Photosensitivity reaction | Photosensitivity reaction NOS | Photosensitivity toxic reaction | Photosensitized | Phototoxicity | Pink macular rash on exposed areas | Rash photosensitivity | Reaction photosensitivity (NOS) | Solar sensitiveness | Sun sensitivity | Photosensitivity reaction (NOS) | Photocontact dermatitis | Phytophotodermatitis | Ultraviolet photosensitivity | Photosensitivity erythema | Dermatitis, Phototoxic | Dermatitis, Contact, Phototoxic | Phototoxic Contact Dermatitis | Contact Dermatitides, Phototoxic | Contact Dermatitis, Phototoxic | Dermatitides, Phototoxic Contact | Dermatitis, Phototoxic Contact | Phototoxic Contact Dermatitides | Phototoxic Dermatitis | Dermatitides, Phototoxic | Phototoxic Dermatitides
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02490Apalutamide0.000334%
BADD_D02492Deflazacort0.000117%
BADD_D02501Sarecycline0.000248%
BADD_D02509Brigatinib0.000716%
BADD_D02510Rucaparib0.008395%
BADD_D02515Pexidartinib0.000627%
BADD_D02549Deucravacitinib0.000820%
BADD_D02552Encorafenib0.000246%
BADD_D02577Oseltamivir acid0.000545%
BADD_D02592Risdiplam0.012354%
BADD_D02636Sulfisoxazole--
The 17th Page    First    Pre   17    Total 17 Pages